News

You are here

Novosanis will present its VAX-ID™ device platform during BioJapan
"High Frequency Ultrasound to Assess Skin Thickness in Healthy Adults” published in the prestigious peer-reviewed journal VACCINE.
Novosanis announced today their collaboration with ImevaX, a biopharmaceutical company based in Munich, Germany
ANTWERP. POWERED BY CREATIVES. unites award-winning designers during their annual exposition . Novosanis and Voxdale were invited to showcase their innovative health care designs: Colli-Pee...

Pages